PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Response to first drug treatment may signal likelihood of future seizures in people with epilepsy

2012-05-11
(Press-News.org) In a study published in Neurology®, the medical journal of the American Academy of Neurology, Professor Kwan, who is also head of the clinical epilepsy program at the Royal Melbourne Hospital and an international authority in antiepileptic drug development, believes a pattern emerges in the early stages.

"Our research shows a pattern based on how a person responds to initial treatment and specifically, to their first two courses of drug treatment," said Dr Kwan.

For the study, 1,098 people from Scotland between the ages of nine and 93 with newly diagnosed epilepsy were followed for as long as 26 years after being given their first drug therapy. Participants were considered seizure-free if they had no seizures for at least a year without changes in their treatment. If they had further seizures, a second drug was chosen to be given alone or to be added to the first. If seizures continued, a third drug regimen was selected, and the process continued for up to nine drug regimens.

The study found that 50 percent of the people were seizure-free after the first drug tried, 13 percent were seizure-free after the second drug regiment tried and 4 percent were seizure-free after the third. Less than two percent of the participants stopped having seizures on additional drug treatment courses up to the seventh one tried, and none became seizure-free after that.

The research also found that 37 percent of people in the study became seizure-free within six months of treatment. Another 22 percent became seizure-free after more than six months of starting treatment. Both groups continued to be seizure-free. However, 16 percent had fluctuating periods of seizure freedom and relapses, and 25 percent were never seizure-free for one year.

At the end of the study, 749 people (68 percent) were seizure-free and 678 people (62 percent) were on only one drug. The results were independent of the age when the person had the first seizure or the type of epilepsy.

"A person who doesn't respond well to two courses of epilepsy drug treatment should be further evaluated to verify an epilepsy diagnosis and to identify whether surgery or other treatment modalities is the best next step," said Professor Kwan. "While freedom from seizures is the goal of treatment, we still have to consider quality of life issues for each individual patient."

Affecting 50 million people worldwide, epilepsy is the most common serious neurological disorder and a major global public health issue. Identifying drug resistance promptly and understanding the genetic risk factors predisposing to epilepsy and drug resistance can help doctors find better treatment and potentially preventive therapy.

### END


ELSE PRESS RELEASES FROM THIS DATE:

NTU scientists invent superbug killers

2012-05-11
The superbugs have met their match. Conceived at Nanyang Technological University (NTU), it comes in the form of a coating which has a magnetic-like feature that attracts bacteria and kills them without the need for antibiotics. The killer coating, which has shown to destroy 99 per cent of the bacteria and fungi that it comes in contact with, is now being used by two companies: a contact lens manufacturer and a company specialising in animal care products. The next step is to extend its use in a wide range of biomedical and consumer products, ranging from implants ...

Researchers identify genetic mutation causing rare form of spinal muscular atrophy

2012-05-11
LOS ANGELES (May 9, 2012) – Scientists have confirmed that mutations of a gene are responsible for some cases of a rare, inherited disease that causes progressive muscle degeneration and weakness: spinal muscular atrophy with lower extremity predominance, also known as SMA-LED. "Typical spinal muscular atrophies begin in infancy or early childhood and are fatal, involving all motor neurons, but SMA-LED predominantly affects nerve cells controlling muscles of the legs. It is not fatal and the prognosis is good, although patients usually are moderately disabled and require ...

Autumn warning: Cancer-causing skin damage is done when young

2012-05-11
With high UV levels continuing in Queensland this autumn, young people are at risk of suffering the worst skin damage they will receive during their lifetime, research from Queensland University of Technology (QUT) has found. Researcher Professor Michael Kimlin from QUT's AusSun Research Lab said the study found UV exposure during a person's first 18 years of life was the most critical for cancer-causing skin damage and skin aging. Professor Kimlin said while people aged over 50 had the slowest rate of skin degradation, results indicated that damage still occurred even ...

Immune drug doesn't help kids with hard-to-treat kidney disorder

2012-05-11
Highlights Children with a particular kidney immune disorder that is unresponsive to standard treatments do not benefit from the immune drug rituximab. Additional studies are needed to fully understand the disease and to develop effective therapies for hard-to-treat cases. Washington, DC (May 10, 2012) — The drug rituximab, an antibody that targets the immune system and is often used to treat immune disorders such as lymphoma and arthritis, has recently emerged as a potential treatment for a childhood kidney disorder known as idiopathic nephrotic syndrome (INS). While ...

Researchers discover that obesity hinders kidney donation

2012-05-11
Researchers at the Hofstra North Shore-LIJ School of Medicine and Feinstein Institute for Medical Research conducted a retrospective analysis which found that morbid obesity impedes kidney donation. In fact, in the analysis of 104 potential living kidney donors, 23 (22 percent) donors were classified as morbidly obese, only three (13 percent) of whom were able to successfully lose weight and donate their kidney. This data will be presented at the National Kidney Foundation (NKF) 2012 Spring Clinical Meetings, to be held from May 9-13 in Washington, DC. Morbidly obese ...

Neighboring chimp communities have their own nut-cracking styles

2012-05-11
People don't always do as their neighbors do, and the same is true of neighboring chimpanzees. That's according to a report published online on May 10 in the Cell Press journal Current Biology featuring observations of wild chimps as they used hammers to crack nuts. "In humans, cultural differences are an essential part of what distinguishes neighboring groups that live in very similar environments," said Lydia Luncz of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany. "For the first time, a very similar situation has been found in wild chimpanzees ...

Social jetlag is a real health hazard

2012-05-11
Social jetlag—a syndrome related to the mismatch between the body's internal clock and the realities of our daily schedules—does more than make us sleepy. It is also contributing to the growing tide of obesity, according to a large-scale epidemiological study reported online on May 10 in Current Biology, a Cell Press publication. "We have identified a syndrome in modern society that has not been recognized until recently," said Till Roenneberg of the University of Munich. "It concerns an increasing discrepancy between the daily timing of the physiological clock and the ...

Heart attack patients taken to PCI hospitals first treated faster

2012-05-11
Heart attack patients in North Carolina who were rushed directly to hospitals equipped to do percutaneous coronary intervention (PCI) received treatment significantly faster than patients first taken to hospitals unequipped to perform PCI and then later transferred for treatment, according to research reported at the American Heart Association's Quality of Care and Outcomes Research 2012 Scientific Sessions. The study focused on the most serious form of heart attack, ST-elevation myocardial infarction (STEMI). A STEMI typically involves complete blockage of the blood ...

Oklahoma City Podiatrist Offers New Patient Services

2012-05-11
Dr. Dale Hall, Oklahoma City podiatrist, is happy to be able to offer new patient services on his practice's website. He hopes the information for new patients makes it easier for patients to find the Oklahoma City, OK podiatrist and schedule appointments. Dr. Hall's website features downloadable new patient forms that can be printed and filled out prior to coming in for the first appointment. This is designed to save time and expedite the process of coming in for a patient's first appointment. Instead of spending a large amount of time filling out forms, new patients ...

Artwork found on walls a first for a Maya dwelling

2012-05-11
WASHINGTON—A vast city built by the ancient Maya and discovered nearly a century ago is finally starting to yield its secrets. Excavating for the first time in the sprawling complex of Xultún in Guatemala’s Petén region, archaeologists have uncovered a structure that contains what appears to be a work space for the town’s scribe, its walls adorned with unique paintings — one depicting a lineup of men in black uniforms — and hundreds of scrawled numbers. Many are calculations relating to the Maya calendar. One wall of the structure, thought to be a house, is covered with ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Response to first drug treatment may signal likelihood of future seizures in people with epilepsy